Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 2Tumor With Alterations of the FGF-R 1Neoplasm Metastasis 1Melanoma 1Lung Neoplasms 1Glioblastoma 1Cholangiocarcinoma 1Breast Neoplasms 1Advanced Gastrointestinal Stromal Tumor (GIST) 1Acrocephalosyndactylia 1

Interventions

infigratinib 1Imatinib Mesylate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Advanced Gastrointestinal Stromal Tumor (GIST) × infigratinib × Clear all
NCT02257541 2020-03-30

BGJ398 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)

Memorial Sloan Kettering Cancer Center

Phase 1/2 Completed
16 enrolled 14 charts
GastrointestinalSarcoma

Advanced Gastrointestinal Stromal Tumor (GIST)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡